Clotrimazole Antifungal Cream Recalled for Manufacturing Compliance Issues
Blossom Pharmaceuticals voluntarily recalls Globe Clotrimazole Cream 1% nationwide due to manufacturing process deviations. Affected lot A472418 has not been linked to illnesses or injuries.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II with no reported illnesses, injuries, or specific identified contamination; voluntary firm-initiated precautionary recall. Meets criteria for Score 2 (voluntary precautionary recalls).
Plain-English summary
Blossom Pharmaceuticals is voluntarily recalling Globe Clotrimazole Cream USP 1% Antifungal Cream (5 oz bottles) distributed nationwide in the USA. The recall affects approximately 14,700 bottles with lot number A472418 and NDC 69396-087-55.
The recall was initiated in response to current Good Manufacturing Practice (cGMP) deviations identified at the manufacturing facility. The firm initiated the recall on October 31, 2025, and notified the FDA on December 2, 2025.
No illnesses or injuries related to this product have been reported to date. Consumers should stop using this product and contact the manufacturer or pharmacy for instructions on return or replacement.
The recalled product
- Product
- CLOTRIMAZOLE (CLOTRIMAZOLE)
- Brand
- CLOTRIMAZOLE
- Manufacturer
- Blossom Pharmaceuticals
- Category
- Drug — Antifungal / Topical
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: A472418
UPCs (1)
- 0094922042002
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CLOTRIMAZOLE
- ModerateClotrimazole Topical Cream Recalled for Manufacturing Practice Deviations
FDA (Drugs) · 2025-12-10
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27